Mirum Pharmaceuticals (MIRM) Work In Process (2021 - 2026)

Mirum Pharmaceuticals' Work In Process history runs 6 years deep, the most recent figure standing at $19.5 million for Q1 2026.

• In Q1 2026, Work In Process rose 23.21% year-over-year to $19.5 million; the TTM figure through Mar 2026 stood at $19.5 million (up 23.21% YoY), while the FY2025 annual figure was $18.5 million, up 14.82% from the prior year.
• Work In Process for Q1 2026 stood at $19.5 million, up from $18.5 million in the prior quarter.
• The five-year high for Work In Process was $19.5 million in Q1 2026, with the low at $553000.0 in Q1 2022.
• The 5-year median for Work In Process is $10.8 million (2024), against an average of $11.3 million.
• The sharpest annual moves came in 2023 and 2025: Work In Process soared 1072.51% in 2023, then advanced 14.82% in 2025.
• Mirum Pharmaceuticals' Work In Process stood at $5.4 million in 2022, then soared by 84.51% to $9.9 million in 2023, then soared by 62.96% to $16.1 million in 2024, then advanced by 14.82% to $18.5 million in 2025, then climbed by 5.49% to $19.5 million in 2026.
• Business Quant data shows MIRM's Work In Process at $19.5 million in Q1 2026, $18.5 million in Q4 2025, and $18.3 million in Q3 2025.